Clinical Trials on Small Cell Lung Carcinoma in Japan
Total 560 results
-
Tomoshi TsuchiyaCompleted
-
Hamamatsu UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityTokyo UniversityCompletedNon-small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.TerminatedNon-small-cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Tokyo UniversityShionogi; National Cancer Center Hospital East; Hokkaido University; Fukushima... and other collaboratorsUnknownNon-small- Cell Lung CancerJapan
-
Tokyo UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknownNon Small Cell Lung CancerJapan
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompleted
-
TakedaRecruitingNon-small Cell Lung Cancer (NSCLC)Japan
-
Wakayama Medical UniversityMerck Sharp & Dohme LLCUnknownSmall Cell Lung Cancer Extensive StageJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-small Cell Lung CancerJapan
-
Shiga UniversityCompletedNon-small Cell Lung CancerJapan
-
Kyowa Kirin Co., Ltd.CompletedAdvanced/Recurrent Non-small-cell Lung CancerJapan
-
National Hospital Organization Nagoya Medical CenterMerck Sharp & Dohme LLC; Central Japan Lung Study GroupActive, not recruitingNon-squamous Non-small-cell Lung Cancer | Cancer, LungJapan
-
Kobe City General HospitalTerminatedAdvanced Non-small Cell Lung CancerJapan
-
Novartis PharmaceuticalsCompleted
-
Kyowa Kirin Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer Stage II | Non-small Cell Lung Cancer Stage IB | Non-small Cell Lung Cancer Stage ⅢAJapan
-
Kyowa Kirin Co., Ltd.Completed
-
Fukushima Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon Small Cell Lung CancerJapan
-
R-PharmCompletedNon-small Cell Lung Cancer (NSCLC)Japan
-
Kyoto UniversityTranslational Research Center for Medical Innovation, Kobe, Hyogo, JapanUnknown
-
Bristol-Myers SquibbCompleted
-
Kanazawa UniversityUnknownNon-Small-Cell Lung CarcinomaJapan
-
Hamamatsu UniversityCompletedNon-Small Cell Lung CancerJapan
-
Sumitomo Pharma Co., Ltd.TerminatedSmall-cell Lung CancerJapan
-
Eisai Co., Ltd.CompletedNon-small-cell Lung CancerJapan
-
Genzyme, a Sanofi CompanyCompleted
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedNon-Small Cell Lung CancerJapan
-
Shiga UniversityHuman Genome Center, Institute of Medical Science, University of TokyoCompletedSmall Cell Lung CancerJapan
-
Bristol-Myers SquibbCompletedNon-Small Cell Lung CancerJapan
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Astellas Pharma Global Development, Inc.Terminated
-
Gunma UniversityJ~pharmaCompletedNon-Small Cell Lung Cancer | AngiogenesisJapan
-
Bristol-Myers SquibbOno Pharma USA IncCompleted
-
Daiichi Sankyo Co., Ltd.TerminatedNon Small Cell Lung CancerJapan
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Bristol-Myers SquibbCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerJapan
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerJapan
-
AstraZenecaCompleted
-
Daiichi Sankyo Co., Ltd.CompletedCervical Cancer | Small Cell Lung Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | Gastric Cancer (Inoperable and Recurrent)Japan
-
Japan Multinational Trial OrganizationCompleted
-
Juntendo UniversityMerck Sharp & Dohme LLCActive, not recruitingNon-squamous Non-small-cell Lung Cancer | EGFR Activating MutationJapan
-
Eli Lilly and CompanyCompletedNon-small Cell Lung Cancer MetastaticJapan
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedNon-Small-Cell Lung CarcinomaJapan